The Historical Evolution of Nanjing Pharmaceutical Co., Ltd.

Nanjing Pharmaceutical (Group) Co., Ltd. (formerly Nanjing Pharmaceutical Company), the main sponsor of the company, was established on 195 1. Approved by the Secret Office of Nanjing Municipal People's Government (51) No.674 and the Ministry of Health of East China Military and Political Commission No.555, it is a public enterprise, also known as Nanjing Public Pharmaceutical Company, and its administration is under the Nanjing Municipal Health Bureau.

1952 changed its name to Nanjing state-owned pharmaceutical company.

1995, the provincial and municipal pharmaceutical companies were split to establish China Pharmaceutical Company Nanjing Branch.

1958 merged with China medicinal materials company, called "Nanjing Pharmaceutical Company".

198 1, the group company uses the names of "Nanjing Pharmaceutical Supply and Purchasing Station in Jiangsu Province" and "Nanjing Pharmaceutical Company" at the same time.

From 65438 to 0988, the group company became the first enterprise in the pharmaceutical and commercial industry in Jiangsu Province with profits and taxes exceeding 10 million yuan.

During the period of 1993, the profit, tax and sales revenue of the group company ranked first in the pharmaceutical business system of Jiangsu Province. The credit rating of the group company was rated as AAA by Nanjing Credit Rating Committee, and was approved as a joint-stock pilot enterprise by Nanjing Economic Restructuring Committee in the same year.

1994, the group company established the company with its main operating assets, Jiangsu Trust and Investment Company of the People's Construction Bank of China, Nanjing State-owned Assets Management Company and Nanjing Tianyu Medical Device Corporation as sponsors, and adopted the method of targeted fundraising. In the same year, the company realized a profit of 20,473,700 yuan, an increase of 77.06% over the previous year, ranking first among similar pharmaceutical enterprises in Jiangsu Province and similar enterprises in the system of the State Administration of Medicine.

1994 10, the company invested 2.95 million yuan to acquire Nanjing Lishui Pharmaceutical Factory (now renamed Nanjing Hengsheng Pharmaceutical Factory), and started technical transformation on 1995.

1trial production was carried out at the end of 995, and 1996 formed a production scale.